genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Roche to Expand Fibrotic Disease Pipeline with Up-to-$1.4B Promedior Acquisition
News
Intestinal Stretch Tells Brain to Switch Off Appetite
Genetics
Dopamine Found to Play Role in Gene Transcription and Cell Proliferation
News
Gut Microbiome Donations from the Old Invigorate the Young
alcohol
Phage Therapy Shows Promise for Alcoholic Liver Disease
Insights
Insights
2020 Vision: Predictions of What May Shape Precision Medicine
Insights
How to Use CRISPR for Site-Specific Epigenetic Editing in the Nervous…
Bioprocessing
The Balance of Bioprocess Models
Insights
A Roadmap and Wish List for Synthetic Genomics
Insights
Improving Integrated Clinical Trial Management Systems through Blockchain
A-Lists
A-Lists
Top 25 Biotech Companies of 2019
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
GEN Edge
Top 10 U.S. Biopharma Clusters
Insights
10 Takeover Targets to Watch This Fall
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Upcoming Webinars
Shake-Up Your Cell Expansion Efforts
Insights
2020 Vision: Predictions of What May Shape Precision Medicine
News
Gut Microbiome Donations from the Old Invigorate the Young
alcohol
Phage Therapy Shows Promise for Alcoholic Liver Disease
Magazine
November 2019 Vol. 39 No. 11
Cold Block
November 2019 Vol. 39 No. 11
Next-Generation Centrifuge
November 2019 Vol. 39 No. 11
Synthetic Biology Seizes New Ground in Healthcare
November 2019 Vol. 39 No. 11
Agrigenomics Yields a Next-Gen Cornucopia
November 2019 Vol. 39 No. 11
Protein-Protein Interactions Get a New Groove On
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Shake-Up Your Cell Expansion Efforts
Upcoming Webinars
Smarter Biobank Management
Upcoming Webinars
An Automated Solution for Single-Cell Gene Expression Workflows
November 2019 Vol. 39 No. 11
Cold Block
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Blood Disorders
Blood Disorders
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Blood Disorders
Celgene, Acceleron Win FDA OK for Drug to Treat Anemia in Adults with Beta Thalassemia
Blood Disorders
NIH, Gates Foundation Commit $200M to HIV, Sickle Cell Gene Therapies
Blood Disorders
Gene Therapy Vehicle for Sickle-Cell Disease Shifts Forward
Blood Disorders
Senescent Cells Promote Blood Clotting
Blood Disorders
CRISPR Editing of Stem Cell Subset Reactivates Fetal Hemoglobin for Treating Genetic Blood Disorders
Blood Disorders
Chimerix Licenses Cantex’s CX-01 for AML after Promising Phase II Results
Blood Disorders
Sepsis Study Reveals Four Subtypes, Suggests Why Some Trials Miss Mark
Blood Disorders
Takeda Sells Two Drugs for $5.7B+, Licenses a Third, in Deals...
Blood Disorders
Sepsis Prediction May be Possible with New Computer Model
Blood Disorders
After 2 Patient Deaths, FDA Imposes Partial Clinical Hold on Trial...
Blood Disorders
Cancer Spread and Blood Clots May Be Halted by Platelet Decoys
Blood Disorders
AbbVie, Lupin to Develop MALT1 Inhibitors for Blood Cancers in $977M+...
Blood Disorders
Celgene, Dragonfly Expand Cancer Immunotherapy Collaboration
Blood Disorders
Lilly, NextCure Launch Cancer Immunotherapy Partnership
Blood Disorders
Spark Therapeutics Stock Tumbles after Mixed Results from Phase I/II Trial...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Spark Therapeutics saw its share price tumble about 30% in early-morning trading after it reported mixed preliminary data this morning from a Phase I/II trial of its hemophilia A gene therapy candidate SPK-8001. [Source: wildpixel/Getty Images]](https://www.genengnews.com/wp-content/uploads/2018/08/Dec7_2017_Getty_487489316_GeneTherapy_60019871441892139879144-324x160.jpg "Spark Therapeutics Stock Tumbles after Mixed Results from Phase I/II Trial of Hemophilia A Candidate")
